Experimental Spinal Cord Injury: Methodological and Neuroimmunological contributions with some Historical background by Fraidakis, Matthew Joseph
 Department of NEUROSCIENCE 
Experimental spinal cord injury  
Methodological and neuroimmunological 
contributions with some historical background 
AKADEMISK AVHANDLING 
som för avläggande av medicine doktorsexamen vid Karolinska 
Institutet offentligen försvaras i Hillarpsalen 
Onsdagen den 9 februari, 2011, kl 09.00 
av 
Matthew J. Fraidakis 
Leg. Läkare 
Huvudhandledare:  
Professor Lars Olson 
Institutionen för Neurovetenskap 
Karolinska Institutet 
 
 
Fakultetsopponent: 
Prof Håkan Aldskogius 
Institutionen för Neurovetenskap 
Enheten for Anatomi 
Uppsala Universitet 
 
Betygsnämnd: 
Professor Lou Brundin 
Institutionen för Klinisk Neurovetenskap 
Enheten för Neurologi 
Karolinska Sjukhuset 
 
Professor Finn Hallböök 
Institutionen för Neurovetenskap 
Uppsala Universitet 
 
Professor Mårten Risling 
Institutionen för Neurovetenskap 
Karolinska Institutet 
 
 
Stockholm 2011 
 
ABSTRACT 
 
Spinal cord injury (SCI) is an incurable neurotraumatic catastrophe that afflicts mostly young individuals with 
resultant functional impairment of varying degrees of severity. The single pharmacologic treatment option at 
present is systemic methylprednisolone administration within 8 hours postinjury oftentimes accompanied by 
neurosurgical interventions. As a rule, SCI becomes a chronic condition with significant handicap for the patient 
and socioeconomic repercussions for the affected families and health care system. Important discoveries in the 
field of central nervous system regeneration since the early 80’s have led to diverse potential therapeutic 
approaches for neuroprotection and repair. Unfortunately, most envisioned treatment apporaches would only be 
applicable at the acute and subacute stages of SCI, thereby excluding the large patient base with chronic SCI. In 
the first part of this thesis work the methodological aspects of a neurosurgical treatment protocol in a rat model of 
acute and chronic SCI were explored. In complete spinal cord transection experiments in rat, the acute and chronic 
spinal cord lesions were characterized with high-resolution magnetic resonance technology. A microneurosurgical 
‘repair’ protocol was employed in both acute and chronic (at 2, 4 or 8 months postinjury) SCI. Behavioral 
evaluation of the operated animals with standard locomotor behavior tests and two novel behavioral tests, 
developed by the author, the Bipedal test and the Head-scratch test, demonstrated a statistically significant 
recovery for those animals that were subjected to the microsurgical reconstruction protocol. Partial functional 
recovery and histologically verifiable axonal regeneration was achieved in rats with both acute and chronic SCI. In 
the second part of this thesis work the neuroinflammatory  and neuroimmunological correlates of peripheral and 
central nervous system injury were studied in mice. In one set of KO mice (TNF, STAT4, STAT6) and their 
corresponding wild type controls, behavioral recovery and axonal regeneration were evaluated after spinal cord 
overhemisection. In another set of KO mice (STAT4, STAT6, IFN, IFNR and IRF1) and their corresponding 
wild type controls  inflammatory and glial cell reactions were assessed after unilateral facial nerve transection 
lesions. The results suggest a positive role for the TH2 subset of the adaptive immune response in anatomic 
recovery after SCI. Finally, in this thesis work the historical origins of the ’inhibitory white matter hypothesis’ 
were researched shedding light on the pioneering work of Lugaro. Future treatments will have to address the 
complexity of SCI with a multipronged approach in order to effect the appropriate type and degree of 
immunomodulation, achieve neuroprotection, and promote collateral sprouting and axonal regeneration ultimately 
resulting in tissue repair and functional recovery. This thesis suggests: 1) that even complete, long-standing SCI 
can be amenable to therapy by demonstrating that the functional incapacity of experimental chronic paraplegia in 
rat is partially reversible, and 2) that judicious modulation of the immune response after SCI may have a role to 
play in axonal regeneration after SCI. 
 
 
